Lauren B. Bonner , Jody D. Ciolino , Keith S. Kaye , Richard G. Wunderink , Denise M. Scholtens
{"title":"关于胜率的能量考虑:基于等级的模拟方法","authors":"Lauren B. Bonner , Jody D. Ciolino , Keith S. Kaye , Richard G. Wunderink , Denise M. Scholtens","doi":"10.1016/j.cct.2025.107937","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The win ratio is an innovative statistical method for evaluating efficacy in clinical trials. The underlying distributions of outcomes, along with potential censoring, ties, and correlations, add complexity to specifying a win ratio for study design purposes. As successful study planning hinges on thorough consideration of sample size and statistical power, we developed a flexible approach to support the use of the win ratio in clinical trials.</div></div><div><h3>Methods</h3><div>We develop a simulation-based approach for study design considerations, relying on the relationship between the win ratio and the rank distribution. We demonstrate that, in the absence of censoring and ties, the strategy samples according to the win ratio specified under the alternative hypothesis. We incorporate administrative censoring, ties, and correlations and conduct a simulation study to evaluate the method in terms of type I error and power. We generate data under specific parametric distributional assumptions and summarize statistical power using sample sizes determined by the rank-based simulation.</div></div><div><h3>Results</h3><div>Results indicate the proposed approach preserves type I error, samples under the assumed win ratio, and provides informative guidance on statistical power for given sample size. The winratiopss R package provides functionality to implement the proposed approach.</div></div><div><h3>Conclusions</h3><div>The simulation strategy offers a novel and flexible approach to inform trial design involving win ratio analysis.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"154 ","pages":"Article 107937"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Power considerations for the win ratio: A rank-based simulation approach\",\"authors\":\"Lauren B. Bonner , Jody D. Ciolino , Keith S. Kaye , Richard G. Wunderink , Denise M. Scholtens\",\"doi\":\"10.1016/j.cct.2025.107937\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The win ratio is an innovative statistical method for evaluating efficacy in clinical trials. The underlying distributions of outcomes, along with potential censoring, ties, and correlations, add complexity to specifying a win ratio for study design purposes. As successful study planning hinges on thorough consideration of sample size and statistical power, we developed a flexible approach to support the use of the win ratio in clinical trials.</div></div><div><h3>Methods</h3><div>We develop a simulation-based approach for study design considerations, relying on the relationship between the win ratio and the rank distribution. We demonstrate that, in the absence of censoring and ties, the strategy samples according to the win ratio specified under the alternative hypothesis. We incorporate administrative censoring, ties, and correlations and conduct a simulation study to evaluate the method in terms of type I error and power. We generate data under specific parametric distributional assumptions and summarize statistical power using sample sizes determined by the rank-based simulation.</div></div><div><h3>Results</h3><div>Results indicate the proposed approach preserves type I error, samples under the assumed win ratio, and provides informative guidance on statistical power for given sample size. The winratiopss R package provides functionality to implement the proposed approach.</div></div><div><h3>Conclusions</h3><div>The simulation strategy offers a novel and flexible approach to inform trial design involving win ratio analysis.</div></div>\",\"PeriodicalId\":10636,\"journal\":{\"name\":\"Contemporary clinical trials\",\"volume\":\"154 \",\"pages\":\"Article 107937\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary clinical trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551714425001314\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425001314","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Power considerations for the win ratio: A rank-based simulation approach
Background
The win ratio is an innovative statistical method for evaluating efficacy in clinical trials. The underlying distributions of outcomes, along with potential censoring, ties, and correlations, add complexity to specifying a win ratio for study design purposes. As successful study planning hinges on thorough consideration of sample size and statistical power, we developed a flexible approach to support the use of the win ratio in clinical trials.
Methods
We develop a simulation-based approach for study design considerations, relying on the relationship between the win ratio and the rank distribution. We demonstrate that, in the absence of censoring and ties, the strategy samples according to the win ratio specified under the alternative hypothesis. We incorporate administrative censoring, ties, and correlations and conduct a simulation study to evaluate the method in terms of type I error and power. We generate data under specific parametric distributional assumptions and summarize statistical power using sample sizes determined by the rank-based simulation.
Results
Results indicate the proposed approach preserves type I error, samples under the assumed win ratio, and provides informative guidance on statistical power for given sample size. The winratiopss R package provides functionality to implement the proposed approach.
Conclusions
The simulation strategy offers a novel and flexible approach to inform trial design involving win ratio analysis.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.